2,011
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype

, , , , , , , , , , , , , , , & ORCID Icon show all
Article: 2094133 | Received 19 Feb 2022, Accepted 21 Jun 2022, Published online: 01 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (1)